ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,068.05
      0.11%
      US Tech 100
      21,095.25
      0.10%
      Dow Jones
      44,680.98
      -0.43%
      Brent Oil
      74.145
      -0.58%
      Bitcoin
      96,524.55
      -0.10%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Eliem Therapeutics Inc (ELYM)

      7. Eliem Therapeutics Inc (ELYM) News

      Eliem Therapeutics Inc

      Eliem Therapeutics Inc (ELYM)

      NASDAQ
      5.11
      0.00
      ( 0.00% )
      Updated: 19:00:00
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      ELYM News

      Official News Only

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      January 15 2025
      ELYM (0.00%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      January 15 2025
      ELYM (0.00%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      January 10 2025
      ELYM (0.00%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      December 20 2024
      ELYM (0.00%)

      Form EFFECT - Notice of Effectiveness
      Edgar (US Regulatory)
      November 25 2024
      ELYM (0.00%)

      Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
      Edgar (US Regulatory)
      November 14 2024
      ELYM (0.00%)

      Form S-3 - Registration statement under Securities Act of 1933
      Edgar (US Regulatory)
      November 12 2024
      ELYM (0.00%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      November 12 2024
      ELYM (0.00%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      October 15 2024
      ELYM (0.00%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      October 02 2024
      ELYM (0.00%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      September 20 2024
      ELYM (0.00%)

      ELYM Discussion

      View Posts
      TimeFades TimeFades 4 months ago
      lol pump n dumped . Manipulation atm see what happens next . Interesting
      👍️0
      Lime Time Lime Time 4 months ago
      Good Luck, hope it goes again. Name Change sometimes comes with catalysts
      👍️0
      TimeFades TimeFades 4 months ago
      It had a nice climb at 930 locked in profits. Did not see a sub 5 move coming. Do or die range now
      👍️0
      Lime Time Lime Time 4 months ago
      ELYM to CLYM, 10/3/2024
      👍️0
      TimeFades TimeFades 4 months ago
      In heavy at 5
      👍️0
      Invest-in-America Invest-in-America 4 months ago
      ELYM: Indeed!! (ELYM's CEO told his Barber early today: "Our Firm got a solid buyout offer from Merck --- but DON'T tell anyone, because the PR about same won't be released until just before the Market Open on 9-25-24!!")
      👍️0
      Awl416 Awl416 4 months ago
      What leaked
      👍️0
      Monksdream Monksdream 9 months ago
      ELYM new 52 high
      👍️0
      Monksdream Monksdream 9 months ago
      ELYM new 52 week high
      👍️0
      Monksdream Monksdream 10 months ago
      ELYM under $5
      👍️0
      Monksdream Monksdream 10 months ago
      ELYM new 52 hi
      👍️0
      Awl416 Awl416 10 months ago
      Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
      👍️0
      Monksdream Monksdream 10 months ago
      ELYM under $3
      👍️0
      Monksdream Monksdream 11 months ago
      ELYM 10Q due March 12
      👍️0

      Your Recent History

      NASDAQ
      ELYM
      Eliem Therapeutics
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads